Evidence map›Paper›PMID 29748442›Full record

ArticleHaematologica2018

Pedro Henrique Prata, Cécile Bally, Thomas Prebet, Christian Recher, Geoffroy Venton, Xavier Thomas, Emmanuel Raffoux, Arnaud Pigneux, Thomas Cluzeau, Judith Desoutter and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Role of Biomarkers in the Management of Acute Myeloid Leukemia.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Review
  8. Does patient fitness play a role in determining first-line treatment of acute myeloid leukemia?Hematology. American Society of Hematology. Education Program · 2020
    Article
  9. Article
  10. Article
  11. Blood advances · 2019
    Article
  12. Minimal/Measurable Residual Disease Monitoring inInternational journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pedro Henrique PrataHématologie Clinique, Hôpital Saint Louis, Paris, France.
Cécile BallyHématologie Clinique, Hôpital Saint Louis, Paris, France.
Thomas PrebetYale Cancer Center, New Haven, CT, USA.
Christian RecherClinical Hematology, IUCT Oncopole, Toulouse University Hospital, France.
Geoffroy VentonPaoli-Calmettes Institute, Marseille, France.
Xavier ThomasLyon-Sud University Hospital, Pierre Bénite, France.
Emmanuel RaffouxHématologie Clinique, Hôpital Saint Louis, Paris, France.
Arnaud PigneuxHematology Department, Centre Hospitalier Universitaire (CHU) de Bordeaux, Universités de Bordeaux, France.
Thomas CluzeauCHU de Nice, France.
Judith DesoutterLaboratoire d'Hématologie, CHRU Lille, Université de Lille, France.
Julie GayService d'Hématologie, Centre Hospitalier de la Côte Basque, Bayonne, France.
Claude PreudhommeCentre de Biologie-Pathologie, Centre Hospitalier Universitaire de Lille, France.
Pierre FenauxHopital Saint-Louis, Paris, France.
Lionel AdèsHématologie Clinique, Hôpital Saint Louis, Paris, France lionel.ades@aphp.fr.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMutationAgedAged, 80 and overAntineoplastic AgentsDisease-Free SurvivalFemaleHumansMaleMiddle AgedNeoplasm ProteinsNuclear ProteinsNucleophosminRemission InductionRetrospective StudiesSurvival RateAntineoplastic AgentsNeoplasm ProteinsNPM1 protein, humanNuclear ProteinsNucleophosmin

Identifiers

PMID29748442
PMCPMC6165814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.